JPRN-UMIN000000601已完成4 期
A multicenter open-label randomized controlled trial comparing continuing lamivudine treatment with switching from lamivudine to entecavir treatment for the patients with chronic hepatitis B or cirrhosis receiving lamivudine administration without lamivudine-resistant YMDD mutant virus. - Switching from lamivudine to entecavir treatment: a randomized controlled trial
Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences0 个研究点目标入组 120 人开始时间: 2007年8月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)The patients who has a history of an allergy against nucleos(t)ide analogues(2)The patients who have received interferon or other nucleoside analogues than lamivudine within 6 months before registration.(3) Pregnant women, or women who are nursing(4)The patients with other chronic liver disease, such as autoimmune hepatitis, primary biliary cirrhosis, alcoholic hepatitis, or chronic hepatitis C.(5)The patients with an uncontrollable heart trouble (myocardial infarction, heart failure, or arrhythmia)(6)The patients with chronic renal failure or chronic respiratory failure(7)The patients who were thought to be inapproriate for this study by the doctor
研究者
相似试验
未知
4 期
A multicenter open-label randomized controlled trial comparing interferon-entecavir sequential therapy with interferon monotherapy for chronic hepatitis Bchronic hepatitis BJPRN-UMIN000000595Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences170
已完成
4 期
A multicenter open-label randomized controlled trial comparing interferon-nucleoside/nucleotide analogues add-on therapy with interferon-nucleoside/nucleotide analogues sequential therapy for chronic hepatitis B.chronic hepatitis BJPRN-UMIN000021768Department of Gastroenterology,Saitama Medical Center, Jichi Medical University60
尚未招募
不适用
A randomized multicenter open-label controlled trial to show that mucous fistula refeeding reduces the time from enterostomy closure to full enteral feeds (MUCous FIstula REfeeding (*MUC-FIRE*) trial)Enterostomymucous fistula refeedingNL-OMON56093niversity of Leipzig, Department of Pediatric Surgery16
尚未招募
Unknown
A multi-center open-label randomized controlled trial to evaluate the efficacy of the Mantis Clip for defect closure following colorectal endoscopic submucosal dissectioJPRN-UMIN000054070The Jikei University School of Medicine250
招募中
不适用
Open-label, multicenter, randomized controlled trials, for comparing remission induction rate of a dose-escalation therapy of methotrexate and an additional combination therapy with bucillamine for naive patients to over 8 mg/weekly of methotrexate.Rheumatoid arthritisJPRN-UMIN000007404KONAMON Study Group90